Skip to Content

Schedule An Appointment

For exceptional cancer care close to home, call:


Active Surveillance / Expectant Management

You may have heard that “most people die with prostate cancer and not from prostate cancer.” While that is partly due to improvements in earlier detection and treatments, certain prostate cancers are not life-threatening. With active surveillance, the urologist can monitor prostate cancer by closely following PSA levels, performing a digital rectal exam and likely repeating biopsies periodically to make sure the cancer has not become more aggressive.

A magnetic resonance imaging (MRI) scan and/or other new molecular testing may be undertaken in select circumstances. If cancer shows signs of progression, intervention and active treatment may be begin. Low-risk cancer patients and/or those patients who have other medical problems with shorter life expectancies are the best candidates for active surveillance. African-American patients are at higher risk for more aggressive prostate cancers and may not always be ideal candidates for active surveillance.

Advantages: Avoids or at least postpones the side effects of therapy such as erectile dysfunction and urinary problems to maintain quality of life.

Disadvantages: There is no way to predict with certainty which cancers are not life-threatening. Therefore, there is a risk the cancer can progress at some point to an incurable stage. In other words, there is a chance of missed opportunity for cure. Also, future treatment can potentially be more challenging after multiple prostate biopsies, which are necessary during surveillance monitoring, and more advanced tumors can be more challenging to treat or cure. Also, some patients experience more anxiety living with an untreated cancer.

Related Content

  • Prostate Cancer Awareness: What You Should Know

    Prostate Cancer Awareness: What You Should Know

    September is Prostate Cancer Awareness Month. Get answers to common questions, debunk myths and learn about risk factors from Lester Borden, MD, in this 2 Your Well-Being discussion with WFMY News 2.
    September 6, 2022
  • Prostate Cancer: When Should You Be Screened?

    Prostate Cancer: When Should You Be Screened?

    Robin Bass, RN, BSN, OCN, talks about what you should know about prostate cancer, including risk factors and screening recommendations.
    September 23, 2019
  • Lester Borden, MD

    What Men of All Ages Should Know About Prostate Cancer

    Prostate cancer is the most common form of cancer in men. It’s important for men of all ages and the women in their lives to understand the risk factors, symptoms and screening recommendations for prostate cancer. Lester Borden, MD, Cone Health Genitourinary Cancer Medical Director, reviews what you should know about prostate cancer.
    September 10, 2019